Overview

Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

This study is conducted in Asia. The aim of this observational study is to evaluate the safety and tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the treatment of Filipino patients with Type 1 and Type 2 Diabetes Mellitus.

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Insulin
Insulin Detemir
Insulin, Globin Zinc